Pharmaceutical compositions comprising Akt protein kinase inhibitors

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 11337977
APP PUB NO 20180055845A1
SERIAL NO

15672505

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention relates to pharmaceutical compositions comprising Akt protein kinase inhibitors with therapeutic activity against diseases such as cancer as well as processes for their preparation and their use as medicament.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GENENTECH INCSOUTH SAN FRANCISCO CA

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Gosselin, Francis South San Francisco, US 59 271
Hell, Andre Basel, CH 3 4
Hidber, Pirmin Basel, CH 13 142
Pepelnjak, Marie Basel, CH 3 4
Reents, Reinhard Basel, CH 23 68
Steidle, Peter Basel, CH 13 19
Wunderlich, Martin Basel, CH 11 39
Yost, Edward South San Francisco, US 6 16

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Nov 24, 2025
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 24, 2029
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 24, 2033
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00